Getinge B, SE0000202624

Getinge B stock heads into the open after a flat close

Published on 09/16/2026 at 07:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 14, 2026, Getinge B stock finished flat at SEK 239.60 on Nasdaq Stockholm. The session range was SEK 238.20 to SEK 239.60, and the Morgan Stanley healthcare conference on September 15, 2026 remains the key scheduled item.

Aquarell der Göteborger Uferpromenade mit Hochhäusern und Hafenkränen
Getinge AB (ISIN SE0000202624) präsentiert die Hafenstadt Göteborg als sanftes Aquarellgemälde mit Bürogebäuden und Kränen, Illustration mit AI erstellt.

Getinge B stock closed at SEK 239.60 on Nasdaq Stockholm on September 14, 2026, unchanged from the previous session. The move came on a range of SEK 238.20 to SEK 239.60, with the close matching the session high.

September 14, 2026 in numbers

Getinge AB (ISIN SE0000202624) held steady as ad hoc news reported that investors were digesting the companys appearance at the Morgan Stanley 24th Annual Global Healthcare Conference. The stock ended the session unchanged at SEK 239.60 after trading between SEK 238.20 and SEK 239.60.

Compared with the last completed session, the share closed at the top of its daily range and sat close to the upper end of the recent trading band. The next scheduled event is the Morgan Stanley healthcare conference transcript dated September 15, 2026, which keeps the stock on watch today.

Conference focus today

Investing.com reported on September 15, 2026 that management highlighted stronger EMEA growth, steadier demand in the United States and continued weakness in China during the Morgan Stanley conference. That discussion also pointed to product innovation and margin expansion as the main themes for investors to follow today.

Disclaimer...

en | SE0000202624 | GETINGE B | boerse | 70108758 | bgmi